Company / Working Capital
Arcutis Biotherapeutics, Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$281.4M
FY2025
5-year range
$254.8M / $399.6M
FY2021-FY2025
Trend
+10.4%
vs FY2024
Sector context
#148 of 213
Health Care
What the data says
At $281M, Arcutis Biotherapeutics, Inc.'s working capital ranks #148 of 213 in the Health Care sector. Working Capital returned to growth in FY2025 after 2 years of decline, reaching $281M.
Based on SEC 10-K filings.
$281M in FY2025 with a 5-year CAGR of +0.8%.
Remained stable around $281M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -11.0%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
#148 of 213 in Health CareTop 69% of 213This company $281.4M Sector average $934.6M
▼
-69.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2025, working capital increased 10.4% year-over-year.
- Ranks #148 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $281.4M | +10.4% |
| FY2024 | $254.8M | -10.2% |
| FY2023 | $283.8M | -29.0% |
| FY2022 | $399.6M | +8.2% |
| FY2021 | $369.4M | +36.7% |
| FY2020 | $270.2M | +166.9% |
| FY2019 | $101.2M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026